Kura Oncology Growth Metrics (2024-2025) | KURA

Growth Metrics Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
EBITDA Margin Growth (1y) -1.28M-1.29M-1.32M
EBITDA Margin (QoQ) 0.01M0.04M-0.80M-0.53M-0.00M0.01M
EBIT Margin Growth (1y) -1.41M-1.44M-1.49M
EBIT Margin (QoQ) 0.02M0.06M-0.90M-0.60M-0.00M0.01M
EBT Margin Growth (1y) -1.28M-1.30M-1.36M
EBT Margin (QoQ) 0.01M0.07M-0.89M-0.47M-0.00M0.01M
Enterprise Value Growth (1y) -111.41%-112.18%-79.03%
Enterprise Value (QoQ) -1.81%-3.24%-104.80%-150.05%-4.78%266.54%
FCF Margin Growth (1y) -1.28M-1.07M-1.09M
FCF Margin (QoQ) -0.18M0.01M-7.72M6.62M0.03M-0.02M
Interest Coverage Ratio Growth (1y) -23.80%-33.77%-40.04%
Interest Coverage Ratio (QoQ) -1.54%-4.62%61.67%-203.97%-9.73%-9.53%
Net Margin Growth (1y) -1.29M-1.30M-1.36M
Net Margin (QoQ) 0.01M0.07M-0.89M-0.47M-0.00M0.01M
Operating Margin Growth (1y) -1.41M-1.44M-1.49M
Operating Margin (QoQ) 0.02M0.06M-0.90M-0.60M-0.00M0.01M
Return on Assets (QoQ) 4.00-3.00-5.00
Return on Capital Employed (QoQ) 5.00-6.00-8.00
Return on Equity (QoQ) -5.00-12.00-20.00
Return on Sales (QoQ) -0.01M713.00251.00